company background image

MariMed OTCPK:MRMD Stock Report

Last Price


Market Cap







27 Sep, 2022


Company Financials +
MRMD fundamental analysis
Snowflake Score
Future Growth1/6
Past Performance2/6
Financial Health6/6

MRMD Stock Overview

MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally.

MariMed Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for MariMed
Historical stock prices
Current Share PriceUS$0.44
52 Week HighUS$0.99
52 Week LowUS$0.40
1 Month Change-28.92%
3 Month Change-2.22%
1 Year Change-52.69%
3 Year Change-51.92%
5 Year Change-8.33%
Change since IPO10.00%

Recent News & Updates

Shareholder Returns

MRMDUS PharmaceuticalsUS Market

Return vs Industry: MRMD underperformed the US Pharmaceuticals industry which returned 3% over the past year.

Return vs Market: MRMD underperformed the US Market which returned -23.7% over the past year.

Price Volatility

Is MRMD's price volatile compared to industry and market?
MRMD volatility
MRMD Average Weekly Movement8.4%
Pharmaceuticals Industry Average Movement11.5%
Market Average Movement6.9%
10% most volatile stocks in US Market15.7%
10% least volatile stocks in US Market2.8%

Stable Share Price: MRMD is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: MRMD's weekly volatility (8%) has been stable over the past year.

About the Company

2011293Bob Fireman

MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company offers cannabis genetics produce flowers and concentrates under the Nature’s Heritage brand; cannabis-infused products in the form of chewable tablets and powder drink mixes under the brand Kalm Fusion; natural fruit chews under the Betty’s Eddies brand; brownies, cookies, and other social sweets under the Bubby’s Baked brand; and cannabidiol formulations under the Florance brand. It also licenses its brands and product formulations, as well as leases cannabis facilities.

MariMed Inc. Fundamentals Summary

How do MariMed's earnings and revenue compare to its market cap?
MRMD fundamental statistics
Market CapUS$149.28m
Earnings (TTM)US$1.52m
Revenue (TTM)US$128.52m


P/E Ratio


P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
MRMD income statement (TTM)
Cost of RevenueUS$62.87m
Gross ProfitUS$65.65m
Other ExpensesUS$64.13m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date


Earnings per share (EPS)0.0045
Gross Margin51.08%
Net Profit Margin1.18%
Debt/Equity Ratio27.4%

How did MRMD perform over the long term?

See historical performance and comparison